EQUIP T 10 DOSE PK PRE FILLED SYRINGES

4.1 Target species Horses from 5 months of age 4.2 Indications for use, specifying the target species For the active immunisation of horses of 5 months of age or older against tetanus to prevent mortality. Duration of immunity is at least 36 months. Onset of immunity is within 2 weeks of completion of the primary course. 4.3 Contraindications None.   4.4 Special warnings The efficacy of active immunisation of young foals against tetanus will be influenced by the level of maternally derived antibodies. This will vary between individuals due to a number of factors, e.g. the immune status of the dam; adequacy of colostral intake by the foal, etc. The vaccine should not be used in foals below 5 months of age, and foals should not be vaccinated until maternally derived antibodies have fallen below protective levels. In any animal population, there may be a small number of individuals which fail to respond fully to vaccination. Successful vaccination depends on storage and administration of the vaccine and the ability of the animal to respond. This can be influenced by such factors as genetic constitution, intercurrent infection, age, nutritional status, concurrent drug therapy and stress. 4.5 Special precautions for use i) Special precautions for use in animals Do not use in unhealthy animals. The product should be administered by respecting appropriate (aseptic) injection technique. ii) Special precautions to be taken by the person administering the veterinary medicinal product to animals In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. 4.6 Adverse reactions (frequency and seriousness) Rarely (<1 in 1000) animals may exhibit a reaction to vaccination. This may be manifest by stiffness, a mild, transient rise in temperature, typically 9-12 hours post vaccination, or a small soft, non-painful local swelling (10-20 mm in diameter) at the injection site. These conditions normally resolve by the day following vaccination. Injection site pain has been reported in very rare cases (<1 in 10, 000). Occasional hypersensitivity reactions may occur. In the event of an allergic or anaphylactic reaction, immediate treatment should be given with a soluble glucocorticoid intravenously or adrenalin intramuscularly. 4.7 Use during pregnancy, lactation or lay The vaccine may be used in pregnant mares which have been vaccinated against tetanus before pregnancy. Heavily pregnant mares should not be subject to undue stress when vaccinated. 4.8 Interaction with other medicinal products and other forms of interaction No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Vat Rate: 20%